This educational supplement to Skin & Allergy News is supported by Neutrogena.
This supplement provides highlights of, and supplemental background information for, the roundtable panel discussion following the Stable Photoprotection Advisory Board Meeting, held October 28, 2005, in Atlanta, GA.
•Topic Highlights
•Faculty
•Target Audience
To view the supplement, click the image above.
Topics
Photoprotection and Our Evolving Understanding of the Effects of Ultraviolet Light
• Introduction
• The Effects of UVA/UVB Radiation
• Sunscreens: A Historical Perspective
• Testing Standards and Labeling Issues
• Public Health Concerns
• Developing the Optimal Sunscreen
• UVA-Specific Photoprotectants
Faculty
Program ChairmanDarrell S. Rigel, MD
Clinical Professor
Deparment of Dermatology
New York University Medical Center
New York, New York
Consultant/Funding for Clinical Grants: Neutrogena Corporation
Diane S. Berson, MD
Assistant Professor
Department of Dermatology
Weill Medical College
Cornell University
New York, New York
Assistant Clinical Professor
Department of Dermatology
New York University School of Medicine
New York, New York
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.
Robert J. Ceilly, MD
Clinical Professor
Department of Dermatology
University of Iowa
Des Moines, Iowa
Consultant: OrthoNeutrogena.
He does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.
Curtis A. Cole, PhD
Senior Director of Technology
Johnson & Johnson Consumer Products Company
Skillman, New Jersey
He is an employee of, directs funding for clinical grants, and holds stock from Johnson & Johnson.
Zoe Diana Draelos, MD
Clinical Associate Professor
Department of Dermatology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Consultant: Neutrogena Corporation.
She does not have any stock interests, equity interests, or patent-licensing arrangements that could be considered a conflict of interest for this supplement.
Target Audience
This supplement has been developed for dermatologists and other health care professionals who are concerned with issues involving photoprotection and who recommend sunscreen products to their patients.
Copyright © 2006 Elsevier Inc.